Related content

Microtubule-interacting drugs for cancer treatment

By Checchi P.M.   Nettles J.H.   Zhou J.   Snyder J.P.   Joshi H.C.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. : 361-365

Elsevier

Access to resources Recommend Favorite

Drugs targeting integrins for cancer therapy

By Binder Mascha   Trepel Martin  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 3, 2009-03 ,pp. : 229-241

Informa Healthcare

Access to resources Recommend Favorite

Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer

By Hare Jennifer I.   Moase Elaine H.   Allen Theresa M.  

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 87-96

Informa Healthcare

Access to resources Recommend Favorite

Targeting the subtypes of breast cancer: rethinking investigational drugs

By Curigliano Giuseppe   Locatelli Marzia   Fumagalli Luca   Brollo Janaina   Munzone Elisabetta   Nolé Franco   Criscitiello Carmen   Goldhirsch Aron  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 191-204

Informa Healthcare

Access to resources Recommend Favorite

Targeting Cancer with Epi-Drugs: A Precision Medicine Perspective

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 10, 2016-08 ,pp. : 856-865

Bentham Science Publishers

Access to resources Recommend Favorite